The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s

@article{Danzon2005TheIO,
  title={The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s},
  author={P. Danzon and Y. Wang and L. Wang},
  journal={Health Economics},
  year={2005}
}
We analyze the effect of price regulation on delays in launch of new drugs. Because a low price in one market may 'spill-over' to other markets, through parallel trade and external referencing, manufacturers may rationally prefer longer delay or non-launch to accepting a relatively low price. We analyze the launch in 25 major markets, including 14 EU countries, of 85 new chemical entities (NCEs) launched between 1994 and 1998. Each NCE's expected price and market size in a country are estimated… Expand
323 Citations

Topics from this paper

Regulation effects on the adoption of new medicines
  • 8
  • Highly Influenced
  • PDF
Should we really worry about “launch delays” of new drugs in OECD countries?
  • 8
  • Highly Influenced
  • PDF
Launching prices for new pharmaceuticals in heavily regulated and subsidized markets
  • 2
  • PDF
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 22 REFERENCES
Trade and Price Differentials for Pharmaceuticals: Policy Options
  • 18
Does Regulation Drive Out Competition in Pharmaceutical Markets?*
  • 231
Do Important Drugs Reach the Market Sooner
  • 151
Introduction of new therapeutic drugs in the United States and Great Britain: An international comparison
  • W. Wardell
  • Political Science, Medicine
  • Clinical pharmacology and therapeutics
  • 1973
  • 112
"An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments": A Comment
  • 82
Survival analysis using the SAS system : a practical guide
  • 2,457
  • Highly Influential
  • PDF
Pricing and Reimbursement in Western Europe 1998: A Concise Guide
  • 1998
London, UK
  • 87
  • PDF
Drug price divergence in Europe: regulatory aspects.
  • C. Huttin
  • Medicine, Economics
  • Health affairs
  • 1999
  • 30
  • PDF
...
1
2
3
...